Katharina is an investment professional working at High-Tech Gründerfonds (HTGF). She is an expert in the early stage financing of life sciences start-ups, particularly in the fields of novel therapeutics and precision medicine. She holds a PhD in medical biology. During her scientific training, Katharina spent time in the US and Asia, among them a research stay at Harvard Medical School. Katharina holds numerous Board and Board Observer positions in European start-ups, among them Akribion Therapeutics, Cutanos, EvlaBio, Fundamental Pharma, Heidelberg Epignostix, Phialogics, and TECregen.